Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
주식 순위 #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
주가
$2.03
시가총액
$121.44M
변동 (1일)
-0.93%
변동 (1년)
-1.97%
국가
FR
거래 Crossject Société Anonyme (ALCJ)

카테고리

Crossject Société Anonyme (ALCJ)의 P/B 비율
July 2026 기준 P/B 비율 TTM: -19.13
Crossject Société Anonyme의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 -19.13입니다. 2023년 말 기준 P/B 비율은 -34.70였습니다.
Crossject Société Anonyme의 P/B 비율 기록 (2010 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) -19.13 -49.09%
2024 -37.58 8.29%
2023 -34.70 -158.98%
2022 58.83 -594.78%
2021 -11.89 -81.50%
2020 -64.28 -524.02%
2019 15.16 54.90%
2018 9.79 46.48%
2017 6.68 29.69%
2016 5.15 -33.97%
2015 7.80 105.46%
2014 3.80 -92.39%
2013 49.91 -339.62%
2012 -20.83 12.72%
2011 -18.48 290.65%
2010 -4.73 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
8.0767 -142.21%
US
1.954 -110.21%
FR
5.8147 -130.39%
DE
8.564 -144.76%
JP
1.7598 -109.20%
US